The inflammatory state seen in CRS is mediated by cytokines such as IL-6 and is often seen after chimeric antigen receptor (CAR)-T cell therapy or with therapeutic monoclonal antibody infusions. The gene discussed is IL6; the disease is congenital rubella syndrome.